Octant Bio
Next-generation small molecule therapeutics. Drugging the cellular mechanisms that cause disease
$80M Series B+ ·
Source: fundraisingfox.com
Latest round on record: Series B+, October 2025, amount undisclosed.
Total raised: $115M across 3 sourced rounds
All 4 rounds ↓Signals
Octant Bio | 118 days from website to first raise on record
Money raised, round by round (amounts linked to their source). Pins are dated signals; hover the icons for dates.
Funding rounds
| Date | Round | Amount | Lead | Source |
|---|---|---|---|---|
| Series B+ | undisclosed | — | fundraisingfox.com | |
| Series B+ | $80M | — | fundraisingfox.com | |
| Series A | $30M | startupintros.com | ||
| Seed | $5M | — | startupintros.com |
Timeline
- X account created
- Website created
Founders and team
SK
Sri Kosuri Cofounder & CEODA
Deepak Agrawal FounderRH
Ramsey Homsany Cofounder & President
Investors
88VC
AAllen & Company
AAndreessen Horowitzlead investor
BBioverge
BBristol-Myers Squibb
CCatalio
FFifty Years
FFlucas Ventures
GGaingels
LLing Wong
- SSujay Jaswa
SSV Angel
WWhat If Ventures
Companies like Octant Bio
DDeepCure$24M Series A · Apr 2024
GGate BioSeed · Nov 2023MModel Medicines$4.1M · Nov 2021
MMatchpoint Therapeutics$150M Series B+ · Oct 2026
RRevier Therapeutics$6.95M Seed · Aug 2026
SStorm Therapeutics$56M Series B+ · Apr 2026
Other companies backed by Andreessen Horowitz
GGeneral Translation$27M Series A · Nov 2026
TTutor Intelligence$75M Series B+ · Nov 2026
NNorthwood$375M Series B+ · Nov 2026
LLarridin$30M Series A · Nov 2026
MMidstream Health$20M Series A · Oct 2026
WWabi$55M Series A · Oct 2026
Andreessen Horowitz portfolio →
Sources and API
Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/octant-bio (get a free API key).